AI Article Synopsis
Article Abstract
Atheroembolic renal disease (AERD), a part of systemic cholesterol embolization syndrome, is caused by the occlusion of small arteries in the kidneys by cholesterol crystal emboli from ulcerated atherosclerotic plaques. Kidney is commonly involved because of its proximity to the abdominal aorta and its enormous blood supply. AERD is an under diagnosed condition. We report eight cases of AERD, highlighting the variability in its clinical presentation and the importance of a renal biopsy to arrive at a definitive diagnosis.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6883863 | PMC |
| http://dx.doi.org/10.4103/ijn.IJN_265_18 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cholesterol Crystal Embolism Following Mechanical Thrombectomy for Acute Ischemic Stroke.
Cureus
October 2024
Department of Neurosurgery, International University of Health and Welfare Narita Hospital, Narita, JPN.
Cholesterol crystal embolism (CCE) is a rare but serious complication of atherosclerotic plaque rupture, often occurring after endovascular interventions. We report the case of a 73-year-old man who developed CCE following mechanical thrombectomy (MT) for an acute ischemic stroke (AIS) due to left internal carotid artery occlusion. The patient, with a history of hypertension and hyperlipidemia, underwent successful MT with complete recanalization.
View Article and Find Full Text PDFArticle Synopsis
- An 80-year-old man experienced worsening kidney function and mobility issues, presenting symptoms like livedo reticularis and gangrene in his legs.
- He was diagnosed with a cholesterol crystal embolism and initially treated with prednisolone and rosuvastatin, but this did not lead to any improvement.
- The patient then underwent a new treatment involving low-density lipoprotein apheresis, which led to improvements in his leg symptoms and allowed for the discontinuation of dialysis.
Blue toe syndrome - systemic cholesterol crystal embolism secondary to cardiovascular procedures: a forensic autopsy report of two cases.
Forensic Sci Med Pathol
November 2024
Department of Legal Medicine, Kyorin University School of Medicine, 6- 20-2 Shinkawa, Mitaka-shi, Tokyo, 181-8611, Japan.
Blue toe syndrome, also referred to as cholesterol crystal embolism is characterized by the distal embolization of cholesterol crystals originating from ruptured atherosclerotic plaques. This condition commonly arises in the context of cardiovascular procedures. Emboli from the thoracoabdominal aorta primarily affect the downstream extremities and intra-abdominal viscera, often resulting in fatal atheroembolic renal failure.
View Article and Find Full Text PDFThe Controversial Role of Glucocorticoids in Atheroembolic Renal Disease: A Narrative Review.
J Clin Med
October 2024
Department of Medicine and Surgery, University of Parma, 43126 Parma, Italy.
Cholesterol crystal embolism (CCE) is an underrecognized multisystemic disease caused by the displacement of cholesterol crystals from atheromatous aortic plaques to distal vascular beds, leading to ischemic injury of target organs, particularly the kidneys, i.e., atheroembolic renal disease (ARD).
View Article and Find Full Text PDFLooking into the cholesterol crystal ball: is complement the answer?
Kidney Int
November 2024
Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Clinical Research, Center for Rare Diseases Aldo e Cele Daccò, Ranica, Bergamo, Italy.
Cholesterol crystal embolism (CCE) is a complication of atherosclerosis and can cause microvascular obstruction in multiple organs. Because the consequences may be fatal, and there is no specific treatment, it is crucial to understand the mechanisms and identify treatment strategies. In this issue, Zhao et al.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!